Literature DB >> 16240487

Dementia associated with alcohol and other drug use.

Gary K Hulse1, Nicola T Lautenschlager, Robert J Tait, Osvaldo P Almeida.   

Abstract

The acute use of alcohol and several other licit and illicit drugs can affect mental state and cognitive function. The chronic use of certain drugs may also increase the risk of cognitive impairment and perhaps dementia in later life. This paper focuses on the long-term cognitive consequences of using alcohol, benzodiazepines, tobacco and cannabis. Currently available evidence indicates that mild to moderate alcohol consumption is not associated with increased risk of cognitive decline and may in fact have a protective effect against dementia, although heavy, long-term consumption is likely to have a negative impact on cognitive function. The degree that alcohol-related cognitive impairment must reach to be classified as dementia is currently obscure. Longer-term smoking is associated with increased risk of cognitive impairment and possibly dementia. The chronic use of benzodiazepines has been associated with increased risk of cognitive impairment but information relating to dementia remains inconclusive. The chronic use of cannabis may impair intellectual abilities but data on this topic remain sparse and difficult to interpret. In conclusion, there is evidence that some drugs contribute to the causal pathway that leads to the development of cognitive impairment but currently available data do not support the introduction of a separate diagnostic category of drug-induced dementia (such as alcohol-related dementia). Health promotion programs designed to decrease tobacco smoking and "harmful" alcohol use (and possibly other drug use) may decrease the burden of cognitive impairment and perhaps dementia in later life.

Entities:  

Mesh:

Year:  2005        PMID: 16240487     DOI: 10.1017/s1041610205001985

Source DB:  PubMed          Journal:  Int Psychogeriatr        ISSN: 1041-6102            Impact factor:   3.878


  15 in total

1.  Driving-Related Cognitive Performance in Older Adults with Pharmacologically Treated Cardiovascular Disease.

Authors:  Sarah Viamonte; David Vance; Virginia Wadley; Dan Roenker; Karlene Ball
Journal:  Clin Gerontol       Date:  2010-04-01       Impact factor: 2.619

Review 2.  Glucocorticoid and polyamine interactions in the plasticity of glutamatergic synapses that contribute to ethanol-associated dependence and neuronal injury.

Authors:  Mark A Prendergast; Patrick J Mulholland
Journal:  Addict Biol       Date:  2011-10-04       Impact factor: 4.280

3.  Association Between Relevant Co-Morbidities and Dementia With Atrial Fibrillation-A National Study.

Authors:  Per Wändell; Axel C Carlsson; Xinjun Li; Jan Sundquist; Kristina Sundquist
Journal:  Arch Med Res       Date:  2019-05-31       Impact factor: 2.235

Review 4.  Gut Microbiota Disorder, Gut Epithelial and Blood-Brain Barrier Dysfunctions in Etiopathogenesis of Dementia: Molecular Mechanisms and Signaling Pathways.

Authors:  Menizibeya O Welcome
Journal:  Neuromolecular Med       Date:  2019-05-21       Impact factor: 3.843

5.  Novel Objective Biomarkers of Alcohol Use: Potential Diagnostic and Treatment Management Tools in Dual Diagnosis Care.

Authors:  Raj K Kalapatapu; R Chambers
Journal:  J Dual Diagn       Date:  2009-01-01

Review 6.  The importance of glucocorticoids in alcohol dependence and neurotoxicity.

Authors:  A K Rose; S G Shaw; M A Prendergast; H J Little
Journal:  Alcohol Clin Exp Res       Date:  2010-09-07       Impact factor: 3.455

7.  Alcohol consumption and cognitive impairment in older men: a mendelian randomization study.

Authors:  Osvaldo P Almeida; Graeme J Hankey; Bu B Yeap; Jonathan Golledge; Leon Flicker
Journal:  Neurology       Date:  2014-02-19       Impact factor: 9.910

Review 8.  The effects of tobacco smoke and nicotine on cognition and the brain.

Authors:  Gary E Swan; Christina N Lessov-Schlaggar
Journal:  Neuropsychol Rev       Date:  2007-08-10       Impact factor: 7.444

9.  [Dementia: diagnosis and therapy].

Authors:  D Kopf; A Rösler
Journal:  Internist (Berl)       Date:  2013-07       Impact factor: 0.743

10.  Patients with chronic kidney disease are at an elevated risk of dementia: a population-based cohort study in Taiwan.

Authors:  Kao-Chi Cheng; Yu-Lung Chen; Shih-Wei Lai; Chih-Hsin Mou; Pang-Yao Tsai; Fung-Chang Sung
Journal:  BMC Nephrol       Date:  2012-09-29       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.